The Centers for Disease Control and Prevention is bleeding out. Over the last year, more than 3,000 employees—over a quarter of the agency's entire workforce—have packed up their desks and walked away. Morale is not just low; it has basically evaporated. Local health departments across the country, left without clear guidance, are struggling to manage local outbreaks on their own. As Dr. David Margolius, Cleveland’s health commissioner, recently put it, local departments are basically forced to "choose your own adventure" rather than follow cohesive national guidelines.
This is the chaotic reality Dr. Erica Schwartz hopes to inherit.
On July 15, 2026, Schwartz stood before the Senate Health, Education, Labor, and Pensions (HELP) Committee. She is President Trump's latest pick to run the Atlanta-based agency. If she gets confirmed, she will be stepping into one of the most politically charged minefields in modern American history.
Can a retired military officer, preventive medicine physician, and corporate executive rescue a collapsing national institution while serving under an HHS Secretary who has spent years questioning established medical science?
The Heavy Weight of a Revolving Door
To understand how high the stakes are, you have to look at the wreckage of the last year.
Since Trump returned to the White House, the CDC has had no permanent leadership. The administration’s first choice, former Florida congressman Dr. David Weldon, saw his confirmation hearing canceled in March 2025 because not enough senators were willing to back him. Next came Susan Monarez. She managed to get confirmed but lasted less than a month before being booted out by Trump officials for not aligning with their political agenda.
Her sudden dismissal sparked a wave of resignations among top scientific leaders. Since then, the agency has been passed around like a hot potato among temporary acting directors. Most recently, National Institutes of Health Director Jay Bhattacharya has been holding the reins.
This leadership vacuum has crippled the CDC. Public health requires consistency. It demands trust. Right now, the public has very little of either.
A Battle Tested Resume Meets Corporate Reality
On paper, Schwartz has the kind of background that makes partisan bickering look silly.
She spent decades in uniform. As a rear admiral in the U.S. Public Health Service Commissioned Corps, she ran the Coast Guard’s medical system. That meant overseeing 41 clinics and 150 sick bays, ensuring that thousands of active-duty service members stayed healthy and fully vaccinated. She also served as deputy surgeon general during the first Trump administration, helping coordinate the federal response during the early, chaotic days of the pandemic.
Oh, and she also holds a law degree and a master’s in public health.
Her former boss, former Surgeon General Jerome Adams, praised her nomination on LinkedIn. He called her a "battle-tested leader" who has the integrity to lead the CDC—assuming she is allowed to follow science without political interference.
But public service is only part of her story. In 2021, Schwartz retired from uniformed service and moved to the private sector. She took a job as president of insurance solutions at UnitedHealth Group, pulling in about $850,000 in salary and bonuses. She also joined the corporate boards of Aveanna Healthcare, Butterfly Network, and the Searching for Solutions Institute.
If confirmed, she will have to walk away from all of that. Her financial disclosures reveal she plans to resign from those boards and cash out her UnitedHealth stock options. That is a massive financial hit to take for a job that promises nothing but long hours, public scrutiny, and political headaches.
The Secret Weapon and the Elephant in the Room
Schwartz has publicly embraced the administration's "Make America Healthy Again" agenda. When Senator Tommy Tuberville asked about her views on nutrition, she declared she was "all in" on tackling chronic illness and improving dietary standards.
That is the easy part. The hard part is dealing with her prospective boss: Health and Human Services Secretary Robert F. Kennedy Jr.
Kennedy has spent years promoting widely discredited theories about vaccines, including the thoroughly disproven link between childhood immunizations and autism. Since taking office, Kennedy has attempted to rewrite vaccine recommendations for children, though a federal judge put some of those changes on hold earlier this year. Under his watch, the CDC has already quietly scaled back programs aimed at smoking prevention and vaccine promotion.
During the hearing, senators wanted to know how Schwartz would handle pressure from a boss who views the public health establishment with deep suspicion.
"I will never compromise on the science," Schwartz told the committee, pledging to use "radical transparency" to win back public trust.
But when pressed on the specifics, her answers became far more evasive.
The Senate Grilling on Vaccines and Political Pressure
The most striking moments of the hearing came when senators from both sides of the aisle pushed Schwartz on whether she has the spine to stand up to political meddling.
Senator Bill Cassidy, a Louisiana Republican and physician who chairs the committee, did not hold back. He pointed out that thousands of kids have ended up hospitalized—and some have died—because of anti-vaccine rhetoric that undermines immunization efforts.
"You can be CDC director and just take orders," Cassidy told her. "We need a CDC director that will actually stand up to crazy, stupid things being said."
When Cassidy asked if she had the firmness to stand up to that political pressure, Schwartz repeated her line about never compromising on science.
"That's not quite the direct answer I'm hoping for," Cassidy shot back.
Democrats were equally frustrated. Senator Maggie Hassan of New Hampshire asked Schwartz if she would refuse an order from Kennedy to suspend flu vaccine promotions during a deadly flu outbreak.
"Senator, I don't speak in hypotheticals," Schwartz responded.
"It isn't hypothetical," Hassan countered. "It happened."
Hassan was referring to internal CDC emails released by Senator Bernie Sanders showing that Kennedy did indeed order CDC staff to halt a flu vaccine campaign last year.
Schwartz also pleaded ignorance on several other controversial moves. She claimed she was unaware that the CDC had scaled back smoking cessation programs. She said she had not seen the CDC webpage that suggests a link between vaccines and autism, though she did agree that scientific evidence shows no such connection exists.
Finding a Path Forward
Despite the dodging, Schwartz is still highly likely to clear the Senate HELP committee and win confirmation from the full Senate. She has the credentials, the military discipline, and the backing of key Republicans.
But winning confirmation is the easy part. Managing the job is where the real struggle begins.
If Schwartz wants to save the CDC, she cannot just hide behind talking points about "radical transparency." She will need to execute a difficult balancing act.
First, she has to rebuild the agency’s ranks. Losing 3,000 experts has left the CDC severely understaffed. She must convince top-tier scientists that Atlanta is still a place where they can do honest, independent research without fear of political retaliation.
Second, she must establish a functional working relationship with Kennedy. She can support the administration’s focus on metabolic health, chronic disease, and nutrition. But she must draw a hard line when it comes to infectious disease control and vaccine safety.
If she cannot or will not draw that line, the CDC’s slide into irrelevance will only continue. And the next time a major public health crisis hits, Americans will find themselves choosing their own adventure in a storm with no lighthouse.
